Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 11481 Download: 520 Citations: 40

Original Article

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2016;22(3):382-389. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0047

View: 10916 Download: 192 Citations: 19

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment

Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi

Clin Mol Hepatol. 2016;22(3):350-358. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0019

View: 7784 Download: 131 Citation: 1

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0021

View: 10243 Download: 155 Citations: 18

Editorial

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

Byoung Kuk Jang

Clin Mol Hepatol. 2016;22(3):336-338. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0104

View: 6931 Download: 110 Citation: 1

Review

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 11644 Download: 372 Citations: 60

Case Report

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases

Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2016;22(2):286-291. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2015.0066

View: 8775 Download: 166 Citations: 13

Original Article

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon

Clin Mol Hepatol. 2016;22(2):241-249. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2015.0053

View: 8778 Download: 131 Citations: 4

Editorial

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?

Hyung Joon Yim

Clin Mol Hepatol. 2016;22(2):238-240. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0103

View: 7356 Download: 91 Citation: 1

Review

Prevention of Hepatitis B reactivation in the setting of immunosuppression

Venessa Pattullo

Clin Mol Hepatol. 2016;22(2):219-237. Published online June 13, 2016

DOI: https://doi.org/10.3350/cmh.2016.0024

View: 15177 Download: 617 Citations: 72

Case Report

Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis

Hye Young Jwa, Yoo-Kyung Cho, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong, Bong Soo Kim, Byoung-Wook Lee, Byung-Cheol Song

Clin Mol Hepatol. 2016;22(1):183-187. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.183

View: 10362 Download: 137 Citations: 4

Original Article

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park

Clin Mol Hepatol. 2016;22(1):152-159. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.152

View: 8379 Download: 92

Review

KASL clinical practice guidelines: management of chronic hepatitis B

Clin Mol Hepatol. 2016;22(1):18-75. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.18

View: 22228 Download: 253 Citations: 129

Case Report

Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein

Jem Ma Ahn, Yong-Han Paik, Jun Hee Lee, Ju Yeon Cho, Won Sohn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo

Clin Mol Hepatol. 2015;21(4):393-397. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.393

View: 7134 Download: 71 Citation: 1

Original Article

Erectile dysfunction in patients with liver disease related to chronic hepatitis B

Min Kim, Seul Young Kim, Woo Sun Rou, Se Woong Hwang, Byung Seok Lee

Clin Mol Hepatol. 2015;21(4):352-357. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.352

View: 8126 Download: 112 Citations: 20

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

Jung Gil Park, Soo Young Park

Clin Mol Hepatol. 2015;21(3):242-248. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.242

View: 7046 Download: 83 Citations: 3

Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure

Jung Min Ha, Won Sohn, Ju Yeon Cho, Jeung Hui Pyo, Kyu Choi, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Yong-Han Paik

Clin Mol Hepatol. 2015;21(3):232-241. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.232

View: 6482 Download: 82 Citations: 7

Review

From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor

Jisu Li, Shuping Tong

Clin Mol Hepatol. 2015;21(3):193-199. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.193

View: 7654 Download: 175 Citations: 10

Original Article

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients

Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim

Clin Mol Hepatol. 2015;21(2):131-140. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.131

View: 6273 Download: 84 Citations: 2

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients

Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa

Clin Mol Hepatol. 2015;21(1):41-48. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.41

View: 6997 Download: 80 Citations: 10

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B

In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim

Clin Mol Hepatol. 2015;21(1):32-40. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.32

View: 8107 Download: 78 Citations: 12

Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir

Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim

Clin Mol Hepatol. 2015;21(1):24-31. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.24

View: 7671 Download: 107 Citations: 14

Review

Personalized treatment of hepatitis B

Anna S. Lok

Clin Mol Hepatol. 2015;21(1):1-6. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.1

View: 7285 Download: 134 Citations: 17

Original Article

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong

Clin Mol Hepatol. 2014;20(4):355-360. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.355 Correction in: Clin Mol Hepatol 2015;21(1):104

View: 6721 Download: 69 Citations: 6

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B

Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol. 2014;20(4):347-354. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.347

View: 7201 Download: 108 Citations: 15

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B

Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2014;20(3):274-282. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.274

View: 5763 Download: 43 Citations: 2

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir

EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee

Clin Mol Hepatol. 2014;20(3):267-273. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.267

View: 6627 Download: 61 Citations: 5

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort

Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park

Clin Mol Hepatol. 2014;20(3):261-266. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.261

View: 7997 Download: 71 Citations: 10

Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers

Kyun-Hwan Kim, Hye-Young Chang, Jun Yong Park, Eun-Sook Park, Yong Kwang Park, Kwang-Hyub Han, Sang Hoon Ahn

Clin Mol Hepatol. 2014;20(3):251-260. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.251

View: 7577 Download: 75 Citations: 9

Editorial

Occult hepatitis B virus infection: clearance or disguise?

Jin-Wook Kim

Clin Mol Hepatol. 2014;20(3):249-250. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.249

View: 6250 Download: 50

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |

Viewed By 5617	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 3585	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 3261	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 2718	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2612	The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology

Cited By 88	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 40	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 36	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 34	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 33	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search